黄瓜短视频

Have any questions? 706-721-6582 or cts@augusta.edu

AU Study Recruitment

Study Name	Principal Investigator
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma	McDonough, Colleen
(DCRI Carra)The Carra Registry: Observational Study of Pediatric Rheumatic Diseases	Patel, Julisa
(MEDLEY) A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children	Patel, Pinkal
(NO1269 Absence) Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel Group Multicenter Study with a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age with Childhood Absence Epilepsy or Juvenile Absence Epilepsy	Park, Yong
Comparison of audiologic screening modalities in patients with cystic fibrosis	Koehn, Heather
GCC2020: Repurposing ibrutinib for chemo-immunotherapy in a phase 1b study of ibrutinib with indoximod plus metronomic cyclophosphamide and etoposide for pediatric patients with brain cancer	Johnson, Theodore
NMTRC 014: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)	McDonough, Colleen
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma	McDonough, Colleen
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG	Johnson, Theodore

RESEARCH. INNOVATION. DISCOVERY.

黄瓜短视频

Research

AU Health

Stay Informed